Literature DB >> 26510945

IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in ovarian cancer cells.

Minghua Zou1, Xianquan Zhang2, Changhua Xu3.   

Abstract

PURPOSE: Ovarian cancer is a highly lethal gynecological malignancy for which the overall prognosis has remained poor over the past few decades. Interleukin (IL6) has been found to be a major contributor to the initiation and progression of ovarian cancer. This cytokine exerts its activity through activation of several signaling pathways, in particular the signal transducer and activator of transcription (STAT3) pathway. Here, we aimed at investigating the capacity of a natural dietary compound found in cruciferous vegetables, i.e., 3,3'-diindolylmethane (DIM), to target the metastatic phenotype of ovarian cancer cells through functional p-STAT3.
METHODS: The human ovarian carcinoma-derived cell lines SKOV3 and A2780 were treated with IL6 and/or DIM and subjected to in vitro proliferation, adhesion, migration and invasion assays to assess the anti-metastatic and anti-IL6 effects of DIM, as well as to assess gene expression alterations before and after shRNA-mediated STAT3 silencing.
RESULTS: We found that DIM inhibits IL6-mediated increases in ovarian cancer cell adhesion, migration and invasion. These results were corroborated by shRNA-mediated STAT3 silencing. Through Western blot and ELISA analyses direct evidence was provided for the capacity of DIM to inhibit ovarian cancer cell adhesion, migration and invasion, which was found to be associated with down-regulation of the matrix metalloproteinases MMP-2 and MMP-9.
CONCLUSIONS: From our data we conclude that DIM exhibits an anti-IL6-like activity by inhibiting p-STAT3 enhanced ovarian cancer cell proliferation and in vitro metastasis-associated events, i.e., adhesion, migration and invasion. Most significantly, MMP-2 and MMP-9, which are known to promote and enhance metastasis, were found to act as targets of DIM. This anti-IL6-like property of DIM may pave the way for the development of novel ovarian cancer preventive and/or therapeutic strategies.

Entities:  

Keywords:  3, 3′-Diindolylmethane; IL6; MMP; STAT3; metastasis; ovarian cancer

Mesh:

Substances:

Year:  2015        PMID: 26510945     DOI: 10.1007/s13402-015-0251-7

Source DB:  PubMed          Journal:  Cell Oncol (Dordr)        ISSN: 2211-3428            Impact factor:   6.730


  44 in total

1.  DIM stimulates IFNgamma gene expression in human breast cancer cells via the specific activation of JNK and p38 pathways.

Authors:  Ling Xue; Gary L Firestone; Leonard F Bjeldanes
Journal:  Oncogene       Date:  2005-03-31       Impact factor: 9.867

2.  Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer.

Authors:  Dejuan Kong; Yiwei Li; Zhiwei Wang; Sanjeev Banerjee; Fazlul H Sarkar
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

3.  Activated STAT3 as a correlate of distant metastasis in prostate cancer: a secondary analysis of Radiation Therapy Oncology Group 86-10.

Authors:  Javier F Torres-Roca; Michelle DeSilvio; Linda B Mora; Li Yan Khor; Elizabeth Hammond; Nazeel Ahmad; Richard Jove; Jeffrey Forman; R Jeffrey Lee; Howard Sandler; Alan Pollack
Journal:  Urology       Date:  2007-03       Impact factor: 2.649

Review 4.  Molecular targets and anticancer potential of indole-3-carbinol and its derivatives.

Authors:  Bharat B Aggarwal; Haruyo Ichikawa
Journal:  Cell Cycle       Date:  2005-09-06       Impact factor: 4.534

5.  2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibits human ovarian cancer cell proliferation.

Authors:  Yan Li; Kai Wang; Yi-Zhou Jiang; Xin-Wen Chang; Cai-Feng Dai; Jing Zheng
Journal:  Cell Oncol (Dordr)       Date:  2014-11-18       Impact factor: 6.730

6.  High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer.

Authors:  Stefania Bellone; Katherine Watts; Stefania Cane'; Michela Palmieri; Martin J Cannon; Alexander Burnett; Juan J Roman; Sergio Pecorelli; Alessandro D Santin
Journal:  Gynecol Oncol       Date:  2005-07       Impact factor: 5.482

7.  STAT3 negatively regulates thyroid tumorigenesis.

Authors:  Joana Pinto Couto; Laura Daly; Ana Almeida; Jeffrey A Knauf; James A Fagin; Manuel Sobrinho-Simões; Jorge Lima; Valdemar Máximo; Paula Soares; David Lyden; Jacqueline F Bromberg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-13       Impact factor: 11.205

Review 8.  Interleukin-6 signaling pathway in targeted therapy for cancer.

Authors:  Yuqi Guo; Feng Xu; TianJian Lu; Zhenfeng Duan; Zhan Zhang
Journal:  Cancer Treat Rev       Date:  2012-05-29       Impact factor: 12.111

Review 9.  Development of a food composition database for the estimation of dietary intakes of glucosinolates, the biologically active constituents of cruciferous vegetables.

Authors:  S A McNaughton; G C Marks
Journal:  Br J Nutr       Date:  2003-09       Impact factor: 3.718

10.  3,3'-Diindolylmethane enhances chemosensitivity of multiple chemotherapeutic agents in pancreatic cancer.

Authors:  Sanjeev Banerjee; Zhiwei Wang; Dejuan Kong; Fazlul H Sarkar
Journal:  Cancer Res       Date:  2009-06-16       Impact factor: 12.701

View more
  26 in total

1.  Relationship between HER2 and JAK/STAT-SOCS3 signaling pathway and clinicopathological features and prognosis of ovarian cancer.

Authors:  An-Quan Shang; Jian Wu; Feng Bi; Yu-Jie Zhang; Lei-Rong Xu; Ling-Ling Li; Fei-Fei Chen; Wei-Wei Wang; Jian-Jun Zhu; You-Yi Liu
Journal:  Cancer Biol Ther       Date:  2017-04-27       Impact factor: 4.742

Review 2.  Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.

Authors:  Khalid El Bairi; Abdul Hafeez Kandhro; Adel Gouri; Wafaa Mahfoud; Noureddine Louanjli; Brahim Saadani; Said Afqir; Mariam Amrani
Journal:  Cell Oncol (Dordr)       Date:  2016-12-15       Impact factor: 6.730

3.  Inhibition of CDK4 sensitizes multidrug resistant ovarian cancer cells to paclitaxel by increasing apoptosiss.

Authors:  Yan Gao; Jacson Shen; Edwin Choy; Henry Mankin; Francis Hornicek; Zhenfeng Duan
Journal:  Cell Oncol (Dordr)       Date:  2017-02-27       Impact factor: 6.730

4.  A heterometallic ruthenium-gold complex displays antiproliferative, antimigratory, and antiangiogenic properties and inhibits metastasis and angiogenesis-associated proteases in renal cancer.

Authors:  Benelita T Elie; Yuriy Pechenyy; Fathema Uddin; María Contel
Journal:  J Biol Inorg Chem       Date:  2018-03-05       Impact factor: 3.358

5.  HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.

Authors:  Suresh Bugide; Vijay Kumar Gonugunta; Vasudevarao Penugurti; Vijaya Lakshmi Malisetty; Ratna K Vadlamudi; Bramanandam Manavathi
Journal:  Cell Oncol (Dordr)       Date:  2016-12-30       Impact factor: 6.730

Review 6.  Role of interleukin-6 in cancer progression and therapeutic resistance.

Authors:  Neeraj Kumari; B S Dwarakanath; Asmita Das; Anant Narayan Bhatt
Journal:  Tumour Biol       Date:  2016-06-03

7.  Radiobiological effects of wound fluid on breast cancer cell lines and human-derived tumor spheroids in 2D and microfluidic culture.

Authors:  Shabnam Jeibouei; Ali Hojat; Ebrahim Mostafavi; Amir Reza Aref; Alireza Kalbasi; Vahid Niazi; Mohammad Ajoudanian; Farzaneh Mohammadi; Fariba Saadati; Seyed Mohammadreza Javadi; Forough Shams; Maryam Moghaddam; Farshid Karami; Kazem Sharifi; Farid Moradian; Mohammad Esmaeil Akbari; Hakimeh Zali
Journal:  Sci Rep       Date:  2022-05-10       Impact factor: 4.996

8.  Blocking interleukin-6 signaling inhibits cell viability/proliferation, glycolysis, and colony forming activity of human medulloblastoma cells.

Authors:  Xiang Chen; Jia Wei; Chenglong Li; Christopher R Pierson; Jonathan L Finlay; Jiayuh Lin
Journal:  Int J Oncol       Date:  2017-11-22       Impact factor: 5.650

9.  High Levels of the Cleaved Form of Galectin-9 and Osteopontin in the Plasma Are Associated with Inflammatory Markers That Reflect the Severity of COVID-19 Pneumonia.

Authors:  Gaowa Bai; Daisuke Furushima; Toshiro Niki; Takashi Matsuba; Yosuke Maeda; Atsushi Takahashi; Toshio Hattori; Yugo Ashino
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

10.  RIPK4 Suppresses the Invasion and Metastasis of Hepatocellular Carcinoma by Inhibiting the Phosphorylation of STAT3.

Authors:  Haoran Li; Dingan Luo; Lakshmi Huttad; Mao Zhang; Youpeng Wang; Juan Feng; Yunfeng Ding; Bing Han
Journal:  Front Mol Biosci       Date:  2021-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.